Böbrek Biyobelirteçleri

Sonuç & Katkı:Bu derlemenin amacı klinik hastalıkların tanısında yardımcı böbrek fonksiyon testlerini, mevcut ve yeni belirteçleri analiz etmektir.

🔬Tür:Literatür & Derleme Çalışması

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Renal hasar morbidite ve mortalite ile yakından ilişkilidir. Erken teşhiste yalnızca serum kreatinin (SCr) düzeyi yeterli olmamaktadır. Bu nedenle son yıllarda yeni biyobelirteçler tanımlanmıştır. Bu derlemenin amacı klinik hastalıkların tanısında yardımcı böbrek fonksiyon testlerini, mevcut ve yeni belirteçleri analiz etmektir.

Abstract

Renal damage is closely related to morbidity and mortality. Measurement of the level of serum creatinine (SCr) is not sufficient in early diagnosis. Therefore, new biomarkers have been identified in recent years. The purpose of this review is to analyze renal function tests which aid in the diagnosis of clinical disease and currently available and new markers.

🔖

Bu Makaleye Atıf Yap

ÖZDEMİR, E., YILDIRIM, Ş., KOÇAN, H. (2022). Böbrek Biyobelirteçleri. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, Cilt: 8 - Sayı: 2, 71–74. https://ajindex.com/articles/551100

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

Mitchell HR and Kline W. Core curriculum in nephrology, Renal Function Testing. Am J Kidney Dis 2006;47:174-83.
Pagana, Kathleen D. Mosby's Manual of Diagnostic and Laboratory Tests. St. Louis Mosby, Inc., 1998 and Rebecca J.F Gale Encyclopedia of Medicine. 2002 3. Villeval'de SV, Gudgalis NI, Kobalava ZhD. Cistatin C as a novel marker of renal function impairement and cardiovascular risk. Kardiologiia 2010;50(6):78-82
Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtrasyon rate? Clin Chem 2002;48:699-707
Randers E, Erlandsen EJ. Serum cystatin C as an endogen marker of renal functions-a review. Clin Chem Lab Med 1997;37(4):389-39
Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M. Comparative Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin C as Early Biomarkers for Early Detection of Renal Failure in Patients with Hypertension. Iran Biomed J 2015;19(2):76-81
Hookham MB, Yu J, et al. Levels of urinary NGAL and KIM-1 early in pregnancy are indicative of subclinical kidney injury in diabetic women who subsequently developed pre-eclampsia. Pregnancy Hypertens 2015;5(1):75-6. http://dx.doi.org/10.1016/j.preghy.2014.10.152.Epub 2015 Feb 23
Petzold K, Poster D, Krauer F, Spanaus K, Andreisek G, Nguyen-Kim TD, et al. Urinary Biomarkers at Early ADPKD Disease Stage. PLoS One 2015;10(4): e0123555.
Matsui K, Kamijo-Ikemorif A, Sugaya T, Yasuda T, Kimura K. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am J Pathol 2011;178(3):1021-32.
Xu Y, Xie Y, Shao X, Ni Z, Mou S L-FABP. A novel biomarker of kidney disease. Clin Chim Acta 2015;445: 85-90. http://dx.doi.org/10.1016/j.cca.2015.03.017.Epub 2015 Mar 20
Yano T, Nozaki Y, Kinoshita K, Hino S, Hirooka Y, Niki K, et al. The pathological role of IL-18R? in renal ischemia/reperfusion injury. Lab Invest 2015;95(1):78- 91. http://dx.doi.org/10.1038/labinvest.2014.120.Epub 2014 Oct 20
Driver TH, Katz R, Ix JH, Magnani JW, Peralta CA, Parikh CR, et al; Health ABC Study. Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Kidney Dis 2014;64(1):49-56. http://dx.doi.org/10.1